TCTMD

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Operators are excited about a device that avoids transapical access, a limitation of other systems, says Gilbert Tang.
TCTMD

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

The device, which is delivered transapically, represents an option for very sick patients who previously have had none.
MassDevice

Data backs Edwards Evoque, Sapien M3 tricuspid, mitral valves

Edwards Lifesciences (NYSE: EW) today shared new data demonstrating successful outcomes with its mitral and tricuspid ...

Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025

Edwards Lifesciences (NYSE: EW) today announced data demonstrating successful patient outcomes supporting its portfolio of mitral and tricuspid therapies. One-year data from the ENCIRCLE single-arm ...
TipRanks on MSN

Edwards Lifesciences’ MITRIS Valve Study: A Potential Game-Changer in Mitral Valve Replacement

Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. Edwards Lifesciences Corp. is conducting a study titled ...
TipRanks on MSN

Edwards Lifesciences Advances Mitral Valve Treatment with SAPIEN X4 Study

Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. Study Overview: Edwards Lifesciences Corp. is conducting a ...
News-Medical.Net on MSN

Clinically significant valvular heart disease vastly underdiagnosed in U.S. elders

Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65-85 living with ...
The Statesman

Renaissance School of Medicine hosts first Aortic Dissection and Aneurysm Awareness Day event

The Department of Surgery at Stony Brook University’s Renaissance School of Medicine hosted its inaugural Aortic Dissection and Aneurysm Awareness Day on Oct. 8 at the Charles B. Wang Center.  The ...